#biotech
Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Hematologic Malignancies Testing Market size & share revenue was valued at approximately USD 3.28 Billion in 2025 and is expected…
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026...
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026 ...
Q-Line Biotec shares to list today. Check GMP ahead of debut
Q-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a significant premium. The company's shares are expected to list at a higher price than the IPO issue price. Q-Line Biotech ope…
US biotech firm Regeneron picks Hyderabad for new GCC
Biotech startup StrainX Bioworks raises $13 million in funding round led by Prime Venture Partners, Leo Capital
StrainX Bioworks, a synthetic biology and precision fermentation startup, has raised $13 million to advance its biotechnology platform. The company, with a team of over 100 experts, aims to scale production to 100,000 litres and forge global partnerships, pos…
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo
The wearables in pharma & biotech market is forecasted to grow from USD 3.98 billion in 2026 to USD 9.97 billion by 2031, at a CAGR of 20.2%. This rapid growth is fueled by advances in biosensor technology, miniaturization, and digitization, supported by stro…
$4 Bn Bioburden Testing Markets, 2022-2024 & 2025-2032 - FDA/EMA Requirements, Rising Biosimilars Production and Advances in Rapid Microbial Detection Technologies Drive Adoption
The bioburden testing market presents opportunities driven by stringent regulations and the need for contamination control in pharma, biotech, and medical devices. Growth is expected in consumables and rapid testing instruments. North America leads due to reg…
Citius raises $36.5m for Lymphir commercialisation
The capital includes a $25m term loan and a warrant exercise agreement expected to yield $11.5m.
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garage
Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who built the company from a garage into a global biotech leader, Kiran is ensuring continuity by handing over to a science-d…